This growth opportunity analytics identifies the developments shaping the global pharmaceutical landscape. The growth of the global pharmaceutical sector will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics.
• Inflation will continue to be a pressing challenge for the pharmaceutical sector in 2023, affecting returns on investment.
• Pharmaceutical companies will continue to shift towards regional rather than global suppliers to ensure geographic proximity and a smoother, more reliable supply chain.
• There will be a strong focus on environmental, social, and governance (ESG) commitments and supply-chain digitalization through lighthouse manufacturing techniques, decentralized clinical trial (DCT) approaches, and the application of artificial intelligence (AI).
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
